Generated: April 28, 2017
|Title:||Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid|
|Abstract:||The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.|
|Inventor(s):||Bieniarz; Christopher (Highland Park, IL), Chang; Steve H. (Gurnee, IL), Cromack; Keith R. (Lake Bluff, IL), Huang; Shuyen L. (Riverwoods, IL), Kawai; Toshikazu (Saitama, JP), Kobayashi; Manami (Saitama, JP), Loffredo; David (Elmhurst, IL), Raghavan; Rajagopalan (Grayslake, IL), Speicher; Earl R. (Buffalo Grove, IL), Stelmach; Honorate A. (Lake Forest, IL)|
|Assignee:||Abbott Laboratories & Central Glass Co LTD (Abbott Park, IL)|
Patent Claim Types:|
see list of patent claims
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Patented / Exclusive Use|
|LIQUID;INHALATION||020478-001||Jun 7, 1995||AN||RX||Yes||Yes||6,288,127*PED||► Subscribe||Y|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.